Verrica Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $32.6M | $15.8M |
| FY2022 | $0 | $40.0M | $34.3M |
| FY2023 | $42.9M | $19.8M | $69.5M |
| FY2024 | $31.0M | $-9.9M | $46.3M |
| FY2025 | $0 | $24.7M | $30.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $32.6M | $15.8M |
| FY2022 | $0 | $40.0M | $34.3M |
| FY2023 | $42.9M | $19.8M | $69.5M |
| FY2024 | $31.0M | $-9.9M | $46.3M |
| FY2025 | $0 | $24.7M | $30.1M |